Marubeni Corporation remains a Buy, driven by value-enhancing M&As and a strengthened A- credit rating. Learn more about MARUY stock here.

Amgen Inc. Buy thesis: strong pipeline, 12% Q3 2025 revenue growth and MariTide obesity upside. Click for this updated look at AMGN stock prospects.

For more than 60 years, this blank slate approach has been the Food and Drug Administration’s gold standard — and for good ...

Chinese stocks might have gone from uninvestable to worth exploring, given the discounted valuations to be had on a number of ...

While Nvidia hasn't put Tesla in checkmate, the company has smartly positioned itself to benefit no matter which automakers ...

The observed near flatness of galactic rotation curves has long been interpreted as evidence for large amounts of non-baryonic dark matter. Here we show that this phenom ...

The 98th annual Academy Award nominees are out, and we're ready to break down their selections for best picture, starting ...

Bounce back it did. Roku stock raced to a 46% gain in 2025, easily outpacing the market's gains. Granted, it's still down 78% ...

High-earnings-yield value stocks CGAU, PAGP, ANGI and SKIL stand out as Trump-led trade threats and geopolitical risks keep ...

With increased volatility could come an opportunity to pick up a steady dividend stock at a slightly lower price and perhaps ...

TCL to take a 51% majority stake in Sony's TV and home audio business. The 'Sony' and 'Bravia' brand names will continue on ...

From Charli XCX to Ethan Hawke, talent will be descending upon Utah for the final time as Sundance looks forward to Boulder ...